Ireland’s ICON signs agreement to acquire PRA Health Sciences
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a...
Irish researchers test alpha-1-antitrypsin for Covid-19
Researchers at RCSI University of Medicine and Health Sciences in Ireland have started a clinical...
Accenture and Bayer to implement INTIENT Clinical platform
Accenture will partner with Bayer to implement the Accenture INTIENT Clinical platform for research, clinical...
PCI Pharma to invest in new clinical facility in Dublin
PCI Pharma is set to invest in a new clinical facility near Dublin, Ireland to...
Alkermes reports positive results for Aristada in schizophrenia
Irish biopharmaceutical company Alkermes has reported positive top-line data from the Phase IIIb ALPINE clinical...
Phase III trial of JZP-258 to treat EDS meets primary endpoint
Jazz Pharmaceuticals has announced that the Phase III trial of JZP-258 for the treatment of...
Allergan’s depression drug fails in Phase III trials
Allergan has reported top-line results from three pivotal Phase III clinical trials of depression drug...
Horizon Pharma announces positive results for teprotumumab
Ireland-based Horizon Pharma has announced positive top-line results from the Phase III confirmatory trial of...
Deals this week: Roivant Sciences, Inflazome, Santhera
Roivant Sciences will use biologic drug candidate SAL200 are entering a global licensing agreement worth...
Shire reports positive data from Phase III lanadelumab trial
Shire has reported positive results from the Phase III hereditary angioedema long-term prophylaxis (HELP) trial...